127 related articles for article (PubMed ID: 15719490)
1. Phase I study of concomitant chemoradiation with raltitrexed in locally advanced head and neck cancer.
Planting A; de Jong M; Jansen P; Kerrebijn J; Smith M; Verweij J
Eur J Cancer; 2005 Jan; 41(1):93-7. PubMed ID: 15719490
[TBL] [Abstract][Full Text] [Related]
2. Raltitrexed ('Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancer.
Botwood N; James R; Vernon C; Price P
Ann Oncol; 2000 Aug; 11(8):1023-8. PubMed ID: 11038040
[TBL] [Abstract][Full Text] [Related]
3. Open label, multi-centre phase II study of raltitrexed ('Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck.
Clarke SJ; Zalcberg J; Olver I; Mitchell PL; Rischin D; Dalley D; Green M; Davidson YE
Ann Oncol; 2000 Feb; 11(2):239-41. PubMed ID: 10761765
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of a fixed dose of cisplatin with increasing doses of raltitrexed (Tomudex) in the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck.
ten Bokkel Huinink D; Tesselaar ME; Baatenburg de Jong RJ; Verschuur HP; Keizer HJ
Ann Oncol; 2001 Mar; 12(3):357-63. PubMed ID: 11332149
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG).
Caponigro F; Comella P; Rivellini F; Avallone A; Budillon A; Di Gennaro E; Mozzillo N; Ionna F; De Rosa V; Manzione L; Comella G
Ann Oncol; 2000 May; 11(5):575-80. PubMed ID: 10907951
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
[TBL] [Abstract][Full Text] [Related]
7. Preoperative chemoradiation with raltitrexed ('Tomudex') for T2/N+ and T3/N+ rectal cancers: a phase I study.
Valentini V; Doglietto GB; Morganti AG; Turriziani A; Smaniotto D; De Santis M; Ratto C; Sofo L; Cellini N
Eur J Cancer; 2001 Nov; 37(16):2050-5. PubMed ID: 11597383
[TBL] [Abstract][Full Text] [Related]
8. Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
Lupattelli M; Maranzano E; Bellavita R; Natalini G; Corgna E; Rossetti R; Trippa F; Mascioni F; Sidoni A; Anselmo P; Buzzi F; Brugia M; Latini P
Tumori; 2005; 91(6):498-504. PubMed ID: 16457149
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant accelerated concomitant boost radiotherapy and multidrug chemotherapy in locally advanced rectal cancer: a dose-escalation study.
Caravatta L; Picardi V; Tambaro R; Padula GD; Macchia G; Deodato F; Massaccesi M; Pacelli F; Berardi S; Ridolfini MP; Di Filippo L; Fabrizio G; Ingrosso M; Cellini N; Valentini V; Morganti AG
Am J Clin Oncol; 2012 Oct; 35(5):424-31. PubMed ID: 21555930
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
Galetta D; Giotta F; Rosati G; Gebbia V; Manzione L; Di Bisceglie M; Borsellino N; Colucci G
Anticancer Res; 2005; 25(6C):4445-9. PubMed ID: 16334124
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group.
Sato A; Kurihara M; Horikoshi N; Aiba K; Kikkawa N; Shirouzu K; Mitachi Y; Sakata Y; Wakui A
Anticancer Drugs; 1999 Sep; 10(8):741-8. PubMed ID: 10573207
[TBL] [Abstract][Full Text] [Related]
13. Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.
Fizazi K; Ducreux M; Ruffié P; Bonnay M; Daniel C; Soria JC; Hill C; Fandi A; Poterre M; Smith M; Armand JP
J Clin Oncol; 2000 Jun; 18(11):2293-300. PubMed ID: 10829050
[TBL] [Abstract][Full Text] [Related]
14. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
[TBL] [Abstract][Full Text] [Related]
15. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
16. Raltitrexed plus radiotherapy for the treatment of unresectable/recurrent rectal cancer: a phase I study.
James RD; Botwood N; Vernon CC; Price P
Ann Oncol; 2003 Apr; 14(4):570-3. PubMed ID: 12649103
[TBL] [Abstract][Full Text] [Related]
17. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials.
Cunningham D; Zalcberg J; Maroun J; James R; Clarke S; Maughan TS; Vincent M; Schulz J; González Barón M; Facchini T
Eur J Cancer; 2002 Mar; 38(4):478-86. PubMed ID: 11872339
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).
Galanis E; Goldberg R; Reid J; Atherton P; Sloan J; Pitot H; Rubin J; Adjei AA; Burch P; Safgren SL; Witzig TE; Ames MM; Erlichman C
Ann Oncol; 2001 May; 12(5):701-7. PubMed ID: 11432631
[TBL] [Abstract][Full Text] [Related]
20. The role of raltitrexed/cisplatin with concurrent radiation therapy in treating advanced cervical cancer.
Li XY; Liu L; Xie XM; Zhou C
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3491-6. PubMed ID: 25491626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
